The role of vascular inflammation markers in deficiency of adenosine deaminase 2

KAYA AKCA Ü., SAĞ E., ÜNAL Ş., KASAP CÜCEOĞLU M., BİLGİNER Y., ÖZEN S.

SEMINARS IN ARTHRITIS AND RHEUMATISM, cilt.51, sa.4, ss.839-844, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.semarthrit.2021.04.013
  • Dergi Adı: SEMINARS IN ARTHRITIS AND RHEUMATISM
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.839-844
  • Anahtar Kelimeler: Deficiency of adenosine deaminase 2, Vascular inflammation, Biomarker, GLYCATION END-PRODUCTS, POLYARTERITIS-NODOSA, SOLUBLE FORM, SERUM-LEVELS, RECEPTOR, EXPRESSION, BIOMARKERS, DISEASE, STROKE, ALPHA
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objectives: The first objective was to assess the role of vascular inflammatory factors in the pathogenesis of deficiency of adenosine deaminase 2 (DADA2) and to compare these markers among DADA2 patients with different phenotypes. We also aimed to investigate differences between DADA2 patients with vasculitic features and classic polyarteritis nodosa (PAN) for the aforementioned markers.